G. Deschênes and A. Leclerc, ??pid??miologie du syndrome n??phrotique de l???enfant, Archives de P??diatrie, vol.17, issue.6, pp.622-623, 2010.
DOI : 10.1016/S0929-693X(10)70028-2

S. Zhang and . Yu, Immunopathogenesis of Idiopathic Nephrotic Syndrome, Contrib. Nephrol, vol.169, pp.94-106, 2011.
DOI : 10.1159/000313947

URL : https://hal.archives-ouvertes.fr/inserm-00596992

A. A. Eddy and J. M. Symons, Nephrotic syndrome in childhood, The Lancet, vol.362, issue.9384, pp.629-639, 2003.
DOI : 10.1016/S0140-6736(03)14184-0

J. R. Hoyer, RECURRENCE OF IDIOPATHIC NEPHROTIC SYNDROME AFTER RENAL TRANSPLANTATION, The Lancet, vol.300, issue.7773, pp.343-348, 1972.
DOI : 10.1016/S0140-6736(72)91734-5

A. A. Ali, Minimal-change glomerular nephritis. Normal kidneys in an abnormal environment?, Transplantation, vol.58, pp.849-52, 1994.

R. Bertelli, Regulatory T cells and minimal change nephropathy: in the midst of a complex network, Clinical & Experimental Immunology, vol.22, issue.2, pp.166-174, 2015.
DOI : 10.1111/cei.12675

K. Kaneko, Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes, World Journal of Pediatrics, vol.5, issue.1, pp.21-28, 2015.
DOI : 10.1007/s12519-015-0003-9

A. Trautmann, Spectrum of Steroid-Resistant and Congenital Nephrotic Syndrome in Children: The PodoNet Registry Cohort, Clinical Journal of the American Society of Nephrology, vol.10, issue.4, pp.592-600, 2015.
DOI : 10.2215/CJN.06260614

S. Santin, Clinical Utility of Genetic Testing in Children and Adults with Steroid-Resistant Nephrotic Syndrome, Clinical Journal of the American Society of Nephrology, vol.6, issue.5, pp.1139-1148, 2011.
DOI : 10.2215/CJN.05260610

D. Mekahli, Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study, Pediatric Nephrology, vol.18, issue.8, pp.1525-1532, 2009.
DOI : 10.1007/s00467-009-1138-5

A. Zagury, Steroid-resistant idiopathic nephrotic syndrome in children: long-term follow-up and risk factors for end-stage renal disease, Jornal Brasileiro de Nefrologia, vol.35, issue.3, pp.191-200, 2013.
DOI : 10.5935/0101-2800.20130031

E. Hodson, N. Willis, and J. Craig, Interventions for idiopathic steroid-resistant nephrotic syndrome in children ( Review ), Cochrane Database Syst. Rev, 2010.

P. Niaudet, Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone, The Journal of Pediatrics, vol.125, issue.6, pp.981-986, 1994.
DOI : 10.1016/S0022-3476(05)82020-7

K. Lieberman and A. Tejani, A Randomized Double-Blind Placebo-Controlled Trial of Cyclosporine in Steroid-Resistant Idiopathic Focal Segmental Glomerulosclerosis in Children, J. Am. Soc. Nephrol, vol.7, pp.56-63, 1996.

M. Van-husen and M. J. Kemper, New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome, Pediatric Nephrology, vol.294, issue.6, pp.881-92, 2011.
DOI : 10.1007/s00467-010-1717-5

E. M. Hodson and J. C. Craig, Therapies for steroid-resistant nephrotic syndrome, Pediatric Nephrology, vol.22, issue.9, pp.1391-1394, 2008.
DOI : 10.1007/s00467-008-0792-3

C. Plank, Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome???a randomized controlled multicentre trial by the Arbeitsgemeinschaft f??r P??diatrische Nephrologie, Pediatric Nephrology, vol.66, issue.9, pp.1483-93, 2008.
DOI : 10.1007/s00467-008-0794-1

M. Liern, V. Reyes, . De, A. Fayad, and G. Vallejo, Use of sirolimus in patients w ith primary steroidresistant nephrotic syndrome, Nefrologia, vol.32, pp.321-329, 2012.

A. Bonanni, A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome, PLOS ONE, vol.84, issue.5, p.138343, 2015.
DOI : 10.1371/journal.pone.0138343.s003

M. Messina, E. Gallo, A. Mella, F. Pagani, and L. Biancone, Update on the treatment of focal segmental glomerulosclerosis in renal transplantation, World Journal of Transplantation, vol.6, issue.1, p.54, 2016.
DOI : 10.5500/wjt.v6.i1.54

K. L. Gibson, D. Glenn, and M. E. Ferris, Back to the Future: Therapies for Idiopathic Nephrotic Syndrome, Blood Purification, vol.39, issue.1-3, pp.105-109, 2015.
DOI : 10.1159/000368951

K. D. Jhaveri, Treatment of Recurrent Focal Segmental Glomerular Sclerosis Posttransplant With a Multimodal Approach Including High-Galactose Diet and Oral Galactose Supplementation, Transplantation, vol.91, issue.6, pp.35-36, 2011.
DOI : 10.1097/TP.0b013e3182088b67

C. Geffriaud-ricouard, P. Jungers, D. Chauveau, and J. P. Grünfeld, Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome, The Lancet, vol.341, issue.8858, p.1475, 1993.
DOI : 10.1016/0140-6736(93)90916-5

S. G. Özlü, Long-term prognosis of idiopathic nephrotic syndrome in children, Renal Failure, vol.14, issue.12, pp.672-677, 2015.
DOI : 10.1007/BF00866371

A. M. Zahran, S. S. Aly, K. I. Elsayh, A. Badawy, and Y. Gamal, Glucocorticoid receptors expression and histopathological types in children with nephrotic syndrome, Renal Failure, vol.24, issue.11, pp.1067-1072, 2014.
DOI : 10.3109/0886022X.2014.917936

A. Hammad, S. Yahia, M. S. Gouida, A. Bakr, and R. M. El-farahaty, Low expression of glucocorticoid receptors in children with steroid-resistant nephrotic syndrome, Pediatric Nephrology, vol.87, issue.5, pp.759-763, 2013.
DOI : 10.1007/s00467-012-2385-4

M. Kirsztajn, G. Nishida, S. K. Silva, M. S. Ajzen, H. Pereira et al., Urinary Retinol-Binding Protein as a Prognostic Marker in the Treatment of Nephrotic Syndrome, Nephron, vol.86, issue.2, pp.109-114, 2000.
DOI : 10.1159/000045727

M. R. Bennett, Urinary Vitamin D-Binding Protein as a Biomarker of Steroid-Resistant Nephrotic Syndrome, Biomarker Insights, vol.11, pp.1-6, 2016.
DOI : 10.4137/BMI.S31633

C. Fede, G. Conti, R. Chimenz, and M. Ricca, N-acetyl-beta-D-glucosaminidase and beta2- microglobulin: prognostic markers in idiopathic nephrotic syndrome, J. Nephrol, vol.12, pp.51-56, 1999.

C. P. Suresh, Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome, Clinical and Experimental Nephrology, vol.8, issue.12, pp.273-283, 2016.
DOI : 10.1007/s10157-015-1162-7

R. M. Lombel, E. M. Hodson, and D. S. Gipson, Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO, Pediatric Nephrology, vol.25, issue.3, pp.409-423, 2013.
DOI : 10.1007/s00467-012-2304-8

C. Faul, The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A, Nature Medicine, vol.14, issue.9, pp.931-939, 2008.
DOI : 10.1038/nm.1857

S. Ho, The Mechanism of Action of Cyclosporin A and FK506, Clinical Immunology and Immunopathology, vol.80, issue.3, pp.40-45, 1996.
DOI : 10.1006/clin.1996.0140

J. Chemli and A. Harbi, Traitement du syndrome n??phrotique idiopathique corticor??sistant, Archives de P??diatrie, vol.16, issue.3, pp.260-268, 2009.
DOI : 10.1016/j.arcped.2008.11.018

S. R. Shah, Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A Review, Global Journal of Health Science, vol.8, issue.4, p.136, 2016.
DOI : 10.5539/gjhs.v8n4p136

Y. Hamasaki, Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis, Pediatric Nephrology, vol.23, issue.5, pp.765-771, 2013.
DOI : 10.1007/s00467-012-2393-4

B. J. Nankivell, C. H. P?ng, P. J. O?connell, and J. R. Chapman, Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology, Transplantation, vol.100, issue.8, pp.1723-1731, 2016.
DOI : 10.1097/TP.0000000000001243

S. Fujinaga and T. Shimizu, Chronic cyclosporine-induced nephrotoxicity in children with steroid-resistant nephrotic syndrome, Pediatric Nephrology, vol.23, issue.10, pp.2065-2071, 2013.
DOI : 10.1007/s00467-013-2535-3

I. Roberti and S. Vyas, Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus, Pediatric Nephrology, vol.24, issue.suppl 1, pp.1117-1141, 2010.
DOI : 10.1007/s00467-010-1471-8

S. Kengne-wafo, Risk Factors for Cyclosporin A Nephrotoxicity in Children with Steroid-Dependant Nephrotic Syndrome, Clinical Journal of the American Society of Nephrology, vol.4, issue.9, pp.1409-1425, 2009.
DOI : 10.2215/CJN.01520209

S. S. Shah and F. Hafeez, Comparison of Efficacy of Tacrolimus Versus Cyclosporine in Childhood Steroid-Resistant Nephrotic Syndrome, J. Coll. Physicians Surg. Pak, vol.26, pp.589-93, 2016.

S. Choudhry, Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial, American Journal of Kidney Diseases, vol.53, issue.5, pp.760-769, 2009.
DOI : 10.1053/j.ajkd.2008.11.033

L. Dehoux, Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome, Pediatric Nephrology, vol.26, issue.11, 2016.
DOI : 10.1542/peds.2008-1559

C. Chan, T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS, Clinical Journal of the American Society of Nephrology, vol.11, issue.8, pp.1360-1368, 2016.
DOI : 10.2215/CJN.11941115

E. M. Hodson, N. S. Willis, and J. C. Craig, Non-corticosteroid treatment for nephrotic syndrome in children, Cochrane Database Syst. Rev, vol.59, issue.2, 2008.
DOI : 10.1002/14651858.CD002290.pub3

N. Larkins, S. Kim, J. Craig, and E. Hodson, Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children, Archives of Disease in Childhood, vol.58, issue.(Suppl 1), pp.404-408, 2016.
DOI : 10.1136/archdischild-2015-308924

O. Boyer, J. K. Moulder, L. Grandin, and M. J. Somers, Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome, Pediatric Nephrology, vol.76, issue.4, pp.575-580, 2008.
DOI : 10.1007/s00467-007-0708-7

V. J. Savin, E. T. Mccarthy, R. Sharma, D. Charba, and M. Sharma, Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity, Translational Research, vol.151, issue.6, 2008.
DOI : 10.1016/j.trsl.2008.04.001

K. Sgambat, M. Banks, and A. Moudgil, Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome, Pediatric Nephrology, vol.5, issue.11, pp.2131-2136, 2013.
DOI : 10.1007/s00467-013-2539-z

E. H. Garin, Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis, Pediatric Nephrology, vol.370, issue.3, pp.469-477, 2015.
DOI : 10.1007/s00467-014-2957-6

M. Delville, B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS, Journal of the American Society of Nephrology, vol.27, issue.8, pp.2520-2527, 2016.
DOI : 10.1681/ASN.2015091002

S. Ernould, Syndrome n??phrotique idiopathique de l???enfant??: incidence, pr??sentation clinique et devenir dans le d??partement de la Gironde, France, Archives de P??diatrie, vol.18, issue.5, pp.522-528, 2011.
DOI : 10.1016/j.arcped.2011.02.012

L. Butani and R. Ramsamooj, Experience with tacrolimus in children with steroid-resistant nephrotic syndrome, Pediatric Nephrology, vol.9, issue.8, pp.1517-1540, 2009.
DOI : 10.1007/s00467-009-1220-z

A. K. Büscher, Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome, Clinical Journal of the American Society of Nephrology, vol.11, issue.2, pp.245-253, 2016.
DOI : 10.2215/CJN.07370715

N. T. Beins and K. M. Dell, Long-Term Outcomes in Children with Steroid-Resistant Nephrotic Syndrome Treated with Calcineurin Inhibitors, Frontiers in Pediatrics, vol.27, issue.3, p.104, 2015.
DOI : 10.1093/ndt/gfr572

D. Habashy, E. M. Hodson, and J. Craig, Interventions for steroid-resistant nephrotic syndrome: a systematic review, Pediatric Nephrology, vol.18, issue.9, pp.906-912, 2003.
DOI : 10.1007/s00467-003-1207-0

A. Jahan, Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome, Pediatric Nephrology, vol.12, issue.11, pp.1961-1967, 2015.
DOI : 10.1007/s00467-015-3133-3

A. Bagga, Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome, Indian Journal of Nephrology, vol.23, issue.1, p.41, 2013.
DOI : 10.4103/0971-4065.107197

A. Bagga, P. Hari, A. Moudgil, and S. C. Jordan, Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome, American Journal of Kidney Diseases, vol.42, issue.6, pp.1114-1120, 2003.
DOI : 10.1053/j.ajkd.2003.08.011

A. Moudgil, A. Bagga, and S. C. Jordan, Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions, Pediatric Nephrology, vol.62, issue.10, pp.1376-81, 2005.
DOI : 10.1007/s00467-005-1964-z

S. Fujinaga, A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome, Pediatric Nephrology, vol.8, issue.1, pp.71-76, 2007.
DOI : 10.1007/s00467-006-0294-0

V. Baudouin, Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial, Pediatric Nephrology, vol.26, issue.3, pp.389-396, 2012.
DOI : 10.1007/s00467-011-2006-7

A. Madani, Effect of levamisole in steroid-dependent nephrotic syndrome, Iran. J. Kidney Dis, vol.4, pp.292-296, 2010.

B. Basu, B. G. Babu, and T. K. Mahapatra, Long-term efficacy and safety of common steroidsparing agents in idiopathic nephrotic children, Clin. Exp. Nephrol, 2016.

A. Sellier-leclerc, Rituximab efficiency in children with steroid-dependent nephrotic syndrome, Pediatric Nephrology, vol.115, issue.6, pp.1109-1115, 2010.
DOI : 10.1007/s00467-010-1465-6

URL : https://hal.archives-ouvertes.fr/hal-00616352

P. Ravani, Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial, Clinical Journal of the American Society of Nephrology, vol.6, issue.6, pp.1308-1315, 2011.
DOI : 10.2215/CJN.09421010

A. Sellier-leclerc, Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery, Nephrology Dialysis Transplantation, vol.27, issue.3, pp.1083-1089, 2012.
DOI : 10.1093/ndt/gfr405

A. Sinha and A. Bagga, Rituximab therapy in nephrotic syndrome: implications for patients' management, Nature Reviews Nephrology, vol.25, issue.3, pp.154-69, 2013.
DOI : 10.1038/nrneph.2012.289

P. Ravani, A. Bonanni, R. Rossi, G. Caridi, and G. M. Ghiggeri, Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children, Clinical Journal of the American Society of Nephrology, vol.11, issue.4, pp.710-720, 2016.
DOI : 10.2215/CJN.08500815

V. Guigonis, Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases, Pediatric Nephrology, vol.65, issue.8, pp.1269-1279, 2008.
DOI : 10.1007/s00467-008-0814-1

URL : https://hal.archives-ouvertes.fr/hal-00453355

K. Kamei, Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome, Pediatric Nephrology, vol.3, issue.7, pp.1181-1187, 2014.
DOI : 10.1007/s00467-014-2765-z

A. Magnasco, Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome, Journal of the American Society of Nephrology, vol.23, issue.6, pp.1117-1141, 2012.
DOI : 10.1681/ASN.2011080775

B. Basu, T. K. Mahapatra, and N. Mondal, Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome, PEDIATRICS, vol.136, issue.1, pp.132-139, 2015.
DOI : 10.1542/peds.2015-0486

B. Wu, Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing, Nephrology, vol.9, issue.1, pp.18-24, 2015.
DOI : 10.1111/nep.12351

R. Coppo, Saquinavir in steroid-dependent and -resistant nephrotic syndrome: a pilot study, Nephrology Dialysis Transplantation, vol.27, issue.5, pp.1902-1912, 2012.
DOI : 10.1093/ndt/gfs035

A. Kashgary, The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series, BMC Nephrology, vol.8, issue.4, p.104, 2016.
DOI : 10.1111/j.1600-6143.2009.02834.x

T. Bosch and T. Wendler, Extracorporeal Plasma Treatment in Primary and Recurrent Focal Segmental Glomerular Sclerosis: A Review, Therapeutic Apheresis, vol.48, issue.Suppl 70, pp.155-160, 2001.
DOI : 10.1111/j.1526-0968.2001.00318.x

S. Feld, Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys, American Journal of Kidney Diseases, vol.32, issue.2, pp.230-237, 1998.
DOI : 10.1053/ajkd.1998.v32.pm9708606

R. Y. Gohh, Preemptive Plasmapheresis and Recurrence of FSGS in High-Risk Renal Transplant Recipients, American Journal of Transplantation, vol.8, issue.6, pp.2907-2919, 2005.
DOI : 10.1111/j.1600-6143.2005.01112.x

H. S. Park, Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients, The Korean Journal of Internal Medicine, vol.29, issue.4, pp.482-490, 2014.
DOI : 10.3904/kjim.2014.29.4.482

H. G. Kang, I. Ha, and H. Cheong, Recurrence and Treatment after Renal Transplantation in Children with FSGS, BioMed Research International, vol.18, issue.6, pp.1-7, 2016.
DOI : 10.1038/ki.2009.377

A. Inaba, Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children, Pediatric Nephrology, vol.7, issue.3, pp.425-434, 2016.
DOI : 10.1007/s00467-015-3174-7

R. Hjorten, Z. Anwar, and K. J. Reidy, Long-term Outcomes of Childhood Onset Nephrotic Syndrome, Frontiers in Pediatrics, vol.18, issue.6, 2016.
DOI : 10.1007/s10157-014-0941-x

D. S. Gipson, Differential risk of remission and ESRD in childhood FSGS, Pediatric Nephrology, vol.13, issue.3, pp.344-349, 2006.
DOI : 10.1007/s00467-005-2097-0

D. 'agati, V. D. Kaskel, F. J. Falk, and R. J. , Focal Segmental Glomerulosclerosis, New England Journal of Medicine, vol.365, issue.25, p.2398, 2011.
DOI : 10.1056/NEJMra1106556

S. Fujinaga and Y. Urushihara, Favorable outcome in children with idiopathic steroid-resistant nephrotic syndrome due to mesangial hypercellularity: A distinct disease entity?, Pediatric Nephrology, vol.28, issue.3, pp.509-510, 2016.
DOI : 10.1007/s00467-015-3229-9

E. Inguuil, Pediatric Nephrology Racial differences in the incidence and renal outcome of idiopathic, Am. J. Public Health, pp.393-397, 1991.

R. Chanchlani and R. S. Parekh, Ethnic Differences in Childhood Nephrotic Syndrome, Frontiers in Pediatrics, vol.43, issue.4, 2016.
DOI : 10.1038/ng.787